How Celldex Therapeutics, Inc. (CLDX) Bulls Placed Winning Bets

Friday's call buyers are cheering Celldex Therapeutics, Inc.'s news-induced rally

Digital Content Group
Nov 17, 2014 at 10:27 AM
facebook twitter linkedin

Celldex Therapeutics, Inc. (NASDAQ:CLDX) has popped nearly 28% out of the gate to trade at $18.12, on encouraging brain tumor drug trial data, as well as subsequent price-target hikes at Roth Capital (to $43 from $40) and Cowen (to $26 from $22). The brokerage firms also reiterated their respective "buy" and "outperform" ratings. Taken as a whole, this is good news for Friday's call buyers.

Diving into the details, options traded at five times the expected rate on Friday, and CLDX's 30-day at-the-money implied volatility jumped 13.6% to 79.7% -- signaling elevated demand for short-term strikes. Looking more closely, the two most active options expire at the end of this week -- namely, the November 14 and 15 calls, where a total of 6,394 contracts were exchanged.

The majority of the volume at both strikes crossed at the ask price, and open interest rose over the weekend, indicating buy-to-open activity. In other words, the traders gambled that CLDX would topple the respective strike prices by week's end -- something that has already come to fruition, thanks to this morning's bullish gap.

In fact, Friday's Celldex Therapeutics, Inc. (NASDAQ:CLDX) traders are already staring at potential paper profits. Specifically, the November 14 call buyers paid a volume-weighted average price (VWAP) of $0.84, and the bid price on this contract is currently $3.60. Similarly, the November 15 call buyers shelled out a VWAP of $0.73, and the bid is now $2.70.


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!